Introduction: What they say: A recent study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708,…
read moreWhat they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac aging and function.” This study was published, in the 7 March 2013 issue of the journal Nature, by Prof Dimmler, Boon, and…
read moreIntroduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was published, in the 6 April…
read moreIntroduction: What they say: A recent study from Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA; and Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston,…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Repurposing the reproductive hormone relaxin into a cardioprotective drug : Cardiac rejuvenation therapy: Relaxin, a protein hormone that facilitates…
read moreWhat we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:Vaccinate yourself with Bacillus Calmette Guerin (BCG)/TB vaccine to keep cardiac diseases at bay: TB/BCG vaccine-based cardiac rejuvenation therapy:…
read more





